Dea Kastrati

We’ve developed a comprehensive fact sheet on the side effects, drug interactions, and cost savings of Nurtec ODT for migraine for clinicians to share with their patients.

LivaNova, a medical technology company, reported positive predictive outcomes from the OSPREY trial of the aura6000TM Hypoglossal Nerve Stimulator System for the treatment of moderate to severe OSA.

Researchers evaluated the safety and efficacy of brexpiprazole for agitation associated with Alzheimer dementia using phase 3 trial data.

Researchers characterized the temporal changes in addiction treatment initiation, engagement, and retention among adolescents during the COVID-19 pandemic.